89bio, Inc. Rings The Closing Bell
ABOUT THIS EVENT
89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, rings the Nasdaq Closing Bell remotely from across the country.
Rohan Palekar, CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.